Therapeutic Uses
Anti-Cancer / Oncology
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
(6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl)ethoxy-1,1,2,2-d4)phenyl)methanone
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Yes -Refer MSDS for accurate information
Raloxifene-d4 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Raloxifene-d4 usage and description
Raloxifene D4 is a deuterated form of the drug Raloxifene, which is a selective estrogen receptor modulator (SERM) that is primarily used for the prevention and treatment of osteoporosis in postmenopausal women. Raloxifene D4 is a labeled analog of Raloxifene, which means that it contains four deuterium atoms that have replaced four hydrogen atoms in the molecular structure of the drug. This modification does not alter the therapeutic efficacy of the drug, but rather it enables scientists to track the drug’s pharmacokinetics and metabolism using isotopic labeling techniques.
In terms of chemical information, Raloxifene D4 has a molecular formula of C28H29D4NO4S and a molecular weight of 498.70 g/mol. It is a white to off-white powder that is slightly soluble in water and freely soluble in methanol. The drug is metabolized by the liver and excreted in the feces. Raloxifene D4 has a half-life of approximately 27 hours, which means that it can be administered once daily with a recommended dose of 60 mg.
In conclusion, Raloxifene D4 is a useful tool for researchers who are studying the pharmacokinetics and metabolism of Raloxifene. It is a safe and effective drug that is commonly used for the prevention and treatment of osteoporosis in postmenopausal women. However, it is important to note that Raloxifene D4 should only be used under the guidance of a healthcare professional.
